Dr. Benjamin Tan, MD
Claim this profileWashington University School of Medicine
Studies Gastroesophageal Junction Adenocarcinoma
Studies Pancreatic Cancer
22 reported clinical trials
64 drugs studied
Area of expertise
1Gastroesophageal Junction Adenocarcinoma
Stage III
Stage IV
Stage I
2Pancreatic Cancer
Stage III
Stage IV
PD-L1 positive
Affiliated Hospitals
Clinical Trials Benjamin Tan, MD is currently running
Combination Chemotherapy
for Biliary Tract Cancer
This trial is testing a new combination of three drugs for patients with advanced biliary tract cancers who did not respond well to their first treatment. The drugs work together to damage the cancer cells' DNA and stop them from growing. The goal is to find a better second-line treatment for these patients. Previous tests with similar drugs did not show improvement.
Recruiting1 award Phase 29 criteria
Cabozantinib
for Neuroendocrine Cancer
High grade neuroendocrine neoplasm patients are treated with platinum doublets such as carboplatin and etoposide mimicking the current guidelines for small cell lung cancer (SCLC). Unfortunately, recurrences are common and most patients with metastatic disease succumb to it within a year. There is no extensive literature or consensus on second- or third-line options (which include FOLFOX, FOLFIRI, capecitabine and temozolomide, taxanes or immunotherapy) and there is urgent need for better regimens.
Recruiting1 award Phase 2
More about Benjamin Tan, MD
Clinical Trial Related6 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Benjamin Tan, MD has experience with
- Nivolumab
- Leucovorin
- Capecitabine
- Trastuzumab
- Defactinib
- Bevacizumab
Breakdown of trials Benjamin Tan, MD has run
Gastroesophageal Junction Adenocarcinoma
Pancreatic Cancer
Cancer
Skin Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Benjamin Tan, MD specialize in?
Benjamin Tan, MD focuses on Gastroesophageal Junction Adenocarcinoma and Pancreatic Cancer. In particular, much of their work with Gastroesophageal Junction Adenocarcinoma has involved Stage III patients, or patients who are Stage IV.
Is Benjamin Tan, MD currently recruiting for clinical trials?
Yes, Benjamin Tan, MD is currently recruiting for 6 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Benjamin Tan, MD has studied deeply?
Yes, Benjamin Tan, MD has studied treatments such as Nivolumab, Leucovorin, Capecitabine.
What is the best way to schedule an appointment with Benjamin Tan, MD?
Apply for one of the trials that Benjamin Tan, MD is conducting.
What is the office address of Benjamin Tan, MD?
The office of Benjamin Tan, MD is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.